EDITCO
LIVE

Serial Number

98425752

Owner

Editco Bio Inc.

Attorney

Brian M. Davis

Filing Date

Feb 28, 2024

Add to watchlist:

No watchlists yet
View on USPTO

EDITCO Trademark

Serial Number: 98425752

EDITCO is a trademark filed by Editco Bio Inc. on February 28, 2024. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Editco Bio Inc. (8 trademarks)

600 Saginaw Drive
Redwood City, CA 94063

Entity Type: 03

Synthego Corporation (10 trademarks)

Ste. A 3696 Haven Ave.
Redwood City, CA 94063

Entity Type: 03

Trademark Details

Filing Date

February 28, 2024

Registration Date

Not Registered

Published for Opposition

October 14, 2025

Goods & Services

Reagents and cells for medical use; Reagents for medical use; Medical diagnostic reagents

Reagents, assays and cells for scientific and research use for development and manufacture of pharmaceuticals, diagnostics and therapeutics; Assays for research purposes; Biochemical reagents used for non-medical purposes; Biochemicals, namely, precursors for in vitro genetic engineering use; Cells for scientific and research use; Cells for scientific, laboratory or medical research; Chemical reagents for non-medical purposes; Chemical reagents, other than for medical or veterinary purposes; Testing kits comprising peptide substrates used in analyzing and detecting certain toxins for research purposes; Diagnostic preparations for scientific or research use other than for medical use; Diagnostic reagents for scientific use; Diagnostic reagents for scientific or research use; Reagents for research purposes; Reagents for scientific and research use; Reagents for scientific or medical research use; Assays and reagents for use in genetic research; Biochemicals, namely, polynucleotides for in vitro and in vivo scientific and research purposes; Chemical solutions and preparations consisting of pre-mixed reactants and reagents for scientific and research use in connection with amplification, analysis or labeling of nucleic acid; Diagnostic reagents and preparations, except for medical or veterinary use; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Nucleic acid sequences and chemical reagents for other than medical and veterinary purposes; Diagnostic preparations, other than for medical purposes; Diagnostic preparations, other than for medical or veterinary purposes

Biochemical research and development; Biotechnology research; DNA analysis services for scientific research purposes; Genetic mapping for scientific purposes; Scientific research; Scientific research and development; Consulting services in the field of biotechnology; Consulting services in the field of pharmaceutical research and development; Consulting services in the field of genetic science; Consulting services in the field of pharmacogenetics; Custom design and development of chemical reagents and biochemical assays; Design, engineering, research, development and testing services in the field of polymeric materials, polymer synthesis, and materials customization for medical, scientific, and technological applications; Research and development in the pharmaceutical and biotechnology fields; Scientific research in the field of genetics and genetic engineering

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 9, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 14, 2025 NPUB
PUBLISHED FOR OPPOSITION
Oct 14, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 8, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 17, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 17, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 17, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 17, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 17, 2025 CNEA
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jun 15, 2025 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 12, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 12, 2024 GNSL
SUSPENSION LETTER WRITTEN
Dec 12, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 1, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 1, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 1, 2024 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Sep 18, 2024 GPRN
PRIORITY ACTION E-MAILED
Sep 18, 2024 GPRA
PRIORITY ACTION WRITTEN
Sep 18, 2024 CPRA
ASSIGNED TO EXAMINER
Sep 16, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 10, 2024 NWOS
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Apr 24, 2024 ASGN
NEW APPLICATION ENTERED
Feb 28, 2024 NWAP